Evidence map›Paper›PMID 24347640›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Dual-modality gene reporter for in vivo imaging.

P Stephen Patrick, Jayne Hammersley, Louiza Loizou, Mikko I Kettunen, Tiago B Rodrigues, De-En Hu, Sui-Seng Tee, Robin Hesketh, Scott K Lyons, Dmitry Soloviev and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Optimization of CEST MRI Reporter Protein Design Using Cation-Pi Networks.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. A genetic reporter for visualizing nitroreductase activity using magnetic resonance imaging.Chemistry methods : new approaches to solving problems in chemistry · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. A programmable genetic platform for engineering noninvasive biosensors.bioRxiv : the preprint server for biology · 2025
    Article
  10. Recent developments in translational imaging of in vivo gene therapy outcomes.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A Genetically Engineered Reporter System Designed forJournal of the American Chemical Society · 2024
    Article
  17. Quantitative in Vivo Molecular MRI.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

P Stephen PatrickDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Jayne Hammersley
Louiza Loizou
Mikko I Kettunen
Tiago B Rodrigues
De-En Hu
Sui-Seng Tee
Robin Hesketh
Scott K Lyons
Dmitry Soloviev
David Y Lewis
Silvio Aime
Sandra M Fulton
Kevin M Brindle

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UK 16465Cancer Research UK 17242Medical Research Council
6 · The paper itself

Abstract

The ability to track cells and their patterns of gene expression in living organisms can increase our understanding of tissue development and disease. Gene reporters for bioluminescence, fluorescence, radionuclide, and magnetic resonance imaging (MRI) have been described but these suffer variously from limited depth penetration, spatial resolution, and sensitivity. We describe here a gene reporter, based on the organic anion transporting protein Oatp1a1, which mediates uptake of a clinically approved, Gd(3+)-based, hepatotrophic contrast agent (gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid). Cells expressing the reporter showed readily reversible, intense, and positive contrast (up to 7.8-fold signal enhancement) in T1-weighted magnetic resonance images acquired in vivo. The maximum signal enhancement obtained so far is more than double that produced by MRI gene reporters described previously. Exchanging the Gd(3+) ion for the radionuclide, (111)In, also allowed detection by single-photon emission computed tomography, thus combining the spatial resolution of MRI with the sensitivity of radionuclide imaging.

Indexed as

Genes, ReporterAnimalsCell Line, TumorContrast MediaFemaleGadoliniumGadolinium DTPAHCT116 CellsHEK293 CellsHumansImage EnhancementIonsMagnetic Resonance ImagingMCF-7 CellsMiceMice, SCIDContrast MediaGadoliniumGadolinium DTPAgadolinium ethoxybenzyl DTPAIonsOrganic Anion TransportersSLCO1A2 protein, humanOatpSPECT

Identifiers

PMID24347640
PMCPMC3890795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.